Link: University of Iowa

Brenner lab treats type 2 diabetic neuropathy with nicotinamide riboside

In the new study, published May 27 in the journal Scientific Reports, Dr. Charles Brenner, together with Randy Kardon, MD, PhD, and Mark Yorek, PhD, who are jointly affiliated with University of Iowa Health Care and the Iowa City VA Health System, and Samuel Trammell (2016 PhD, Brenner laboratory), tested the effects of NR supplementation on mouse models of prediabetes and type 2 diabetes. Read more about their study here:

Leave a Reply

You must be logged in to post a comment.